Dragonfly Biosciences is expanding its CBD extraction capability to enable the large scale delivery of over 1,000kg of CBD per month.
The manufacturers of Dragonfly CBD oil has acquired full ownership of Premium Extraction Services Limited – a large scale state of the art ethanol extraction facility.
As a result Dragonfly Biosciences will be able to offer the large-scale delivery of over 1000kg of CBD per month, in comparison to other extraction facilities which can deliver on average around 50kg per month.
Dragonfly CBD can currently be found at a variety of stockists on the UK high street including Boots, Tesco, Sainsbury’s, as well as in pharmacies.
The expansion will enable the firm to deliver bespoke CBD distillate and CBD isolate in significant quantities, adding to its expanding portfolio.
Chief executive, Regan Saveall, described the move as a “significant step forward” for the company in delivering “first-class” CBD.
He continued: “The acquisition of the Premium Extraction Services Company is a significant step forward for Dragonfly Biosciences and importantly our range of CBD products.
“We are committed to innovation and investment, and already have our own vertical integrated supply chain, which allows us to provide high-quality CBD products, all of which are compliant with all regulatory status.
“The extraction facility will enable us to control and produce even more first-class CBD on a much larger scale. This will support the demand for our current products and allow us to explore different types of CBD offerings. There are only a handful of large-scale fully permitted facilities in the EU, so this is really exciting for us.
“By investing as a company, we can ensure our CBD brand is as always safe, legal and best in class when it comes to quality and consumer transparency. “
The Dragonfly Bioscience extraction plant is based in Romania close to the Bulgarian border and fields where the firm has 650 hectares of organically certified land.
The extraction facility is built to EU-GMP standard with full accreditation status in progress.
This article originally appeared on www.cannabishealthnews.co.uk